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Background: Enlarged perivascular spaces (ePVS) are common finding on magnetic
resonance imaging (MRI) in elderly. ePVS are thought to be associated with cerebral
small vessel disease (SVD) such as white matter hyperintensities (WMH), lacunes, and
cerebral microbleeds (CMBs). However, the different location of SVD and its relationship
to ePVS distribution requires further investigation.
Objective: To study the association between location and severity of SVD with ePVS
from memory clinic and population-based settings.
Methods: This study includes patients from an ongoing memory clinic based
case-control study and participants from the population-based: Epidemiology of
Dementia in Singapore study (EDIS). All participants underwent a comprehensive
standardized evaluation including physical, medical and neuropsychological assessment
and a brain MRI. CMBs and lacune location were categorized into strictly lobar,
strictly deep and mixed, and ePVS location into centrum semiovale and basal ganglia.
WMH volume was automatically segmented and was classified into anterior and
posterior distribution. Negative binomial regression models were constructed to analyse
associations between SVD and ePVS and the rate ratios (RR) and 95% confidence
intervals (CI) were reported.
Results: Of 375 patients (median age = 73 years) from memory clinic and 583
participants (median age = 70 years) from EDIS, the median total ePVS count
was 17.0 and 7.0, respectively. Increased severity of SVD was not associated
with total ePVS counts in both memory clinic and EDIS study. Analysis with the
location of SVD and ePVS also showed similar results. However, in EDIS study,
presence of ≥2 lacunes [RR = 1.61, 95% CI = 1.3, 2.30, p = 0.009], presence
of ≥2 CMBs [RR = 1.40, 95% CI = 1.08, 1.83, p = 0.012], and higher
volume of WMH [RR = 1.41, 95% CI = 1.10, 1.81, p = 0.006] were associated
with basal ganglia ePVS independent of age, gender and vascular risk factors.
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Conclusion: In this study, we found that the ePVS were not associated with the location
and severity of SVD in the memory-clinic patients. However, only severity of SVD was
associated with basal ganglia ePVS in the population-based setting. Our findings will
need to be studied further in different cohorts so as to understand the mechanism
underlying different SVD types in subclinical and clinical phases as well as for predicting
cognitive decline.
Keywords: enlarged perivascular spaces, cerebral small vessel disease, memory clinic, population-based,
magnetic resonance imaging
INTRODUCTION
Cerebral small vessel disease (SVD) is considered as one of
the leading causes of cognitive decline, physical disability and
dementia in the elderly population (1, 2). SVD represents a
group of pathological processes affecting the small arteries,
arterioles, venules, and capillaries in the brain, resulting in
various ischemic, hemorrhagic, and inflammatory damage (1, 3).
White matter hyperintensities (WMH), lacunes, and cerebral
microbleeds (CMBs) are MRI signatures of SVD and have
been extensively studied in relation to cognition, clinical
outcome and associations with other markers of SVD (4–
6). In recent years, enlarged perivascular spaces (ePVS) have
emerged as another feature of SVD, however their occurrence
may also be non-pathogenic as they appear during normal
aging (7).
Perivascular spaces are thought to be interstitial fluid-
filled spaces surrounding the penetrating vessels in the brain.
Physiologically, perivascular spaces are important for the
drainage of interstitial fluid and regulating immune response
(7). When enlarged, these perivascular spaces are commonly
observed on MRI of elderly people (8). ePVS are mainly seen in
the centrum semiovale and basal ganglia but may also appear in
the hippocampus and the brain stem (9).
Previous studies have shown that ePVS are not only
associated with other SVD markers such as WMH, lacunes,
and CMBs (7, 10–12) but also with aging and vascular
risk factors such as hypertension (13–16). By contrast, a
few recent studies have shown that ePVS are not associated
with WMH (16) and other cardiovascular risk factors (7).
Furthermore, it is suggested that different location of ePVS
may indicate different pathophysiological mechanisms such as
cerebral amyloid angiopathy and hypertensive arteriopathy (7,
12). Previous studies have examined centrum semiovale and
basal ganglia ePVS in relation to lobar and deep CMBs (12, 15).
However, very few studies have taken into account the association
between the location of lacunes and WMH with the location of
ePVS (10, 17).
We aim to investigate the association between different
locations and severity of SVD markers such as WMH, lacunes,
and CMBs with different locations of ePVS (centrum semiovale
and basal ganglia) in a spectrum of diseased patients (memory-
clinic) to a population-based (Epidemiology of Dementia in
Singapore study) setting.
MATERIALS AND METHODS
Study Population
In this study, participants were recruited from two studies
in Singapore. The first is a memory-clinic based case-control
study, where patients (age ≥ 50 years) were recruited from
memory clinics at the National University Hospital from August
2010 to December 2016. Cases were participants with subjective
memory complains and impairment on neuropsychological
assessment and were diagnosed with cognitive impairment
no dementia (CIND) and dementia. CIND was defined as
impairment in at least one cognitive domain on comprehensive
neuropsychological test, but did not meet the criteria for
dementia according to Diagnostic and Statistical Manual for
Mental Disorder-Fourth Edition (DSM-IV). Dementia was
diagnosed according to the DSM-IV criteria. The controls
were individuals who had no objective cognitive impairment
on comprehensive neuropsychological tests or any functional
decline and were diagnosed as No Cognitive Impairment (NCI).
Of the total 501 patients from the memory clinics, 18 had
incomplete or poor quality scan, 12 did not undergo MRI scans
(3 were claustrophobic, 1 refused, 2 were uncooperative or could
not follow instructions, and 6 had contraindications for MRI),
and 96 had no ePVS grading (because the primary sequences
required for ePVS grading i.e., T1 and T2-weighted images
were missing and/or had motion artifacts which restricted our
grading), leaving a final sample of 375 cases for analysis.
The second is the Epidemiology of Dementia in Singapore
study (EDIS), which recruited multi-ethnic (Chinese, Indian,
and Malay) participants from the Singapore Epidemiology of
Eye Disease (SEED) study (18). SEED is a large population
based study among Chinese [Singapore Chinese Eye Study
(SCES)], Malay [Singapore Malay Eye Study (SiMES-2)], and
Indians [Singapore Indian Eye Study (SINDI-2)]. Participants
from the SEED study who were ≥60 years and were screened-
positive on the Abbreviated Mental Test (AMT) or self-reported
progressive forgetfulness (PF) were invited to participate in
the EDIS study from August 2010 to July 2015 (19). EDIS
study also used similar diagnostic criteria as memory clinic,
where participants were diagnosed as NCI (individuals who
had no objective cognitive impairment on comprehensive
neuropsychological tests or any functional decline), CIND
(individuals with impairment in at least one cognitive domain
on comprehensive neuropsychological test, but did not meet
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the criteria for dementia according to DSM-IV), and Dementia
(diagnosed according to the DSM- IV criteria).
A total of 300 Chinese and 323 Malay screen-positive
participants agreed to take part in the second phase of this study,
which included an extensive neuropsychological test battery and
brain MRI. The present analysis was restricted to Chinese and
Malay as the ePVS data was only available in these two ethnicities.
Of the 623 participants, 36 had no MRI scans and 4 had poor
quality MRI scans, leaving 583 (284 Chinese and 299 Malays)
cases for the final analysis.
The memory clinic study was approved by the National
Healthcare Group Domain-Specific Review Board. For the EDIS
study, ethics approval was obtained from both the Singapore
Eye Research Institute and National Healthcare Group Domain-
Specific Review Board. This study is conducted in accordance
with the Declaration of Helsinki. A written informed consent
was obtained from all participants or their caregivers prior to the
recruitment for this study.
Demographics and Vascular Risk Factors
All participants were administered a detailed questionnaire to
collect information on age, gender, years of formal education,
and smoking history. Previous medical history of hypertension,
diabetes, and hyperlipidemia was noted and subsequently
verified by medical records. Hypertension was defined as
systolic blood pressure ≥140 mmHg and/or diastolic blood
pressure ≥90 mmHg during the examination, or previous
diagnosis of hypertension, or the use of antihypertensive
medications. Hyperlipidemia was defined as total cholesterol
level≥4.14 mmol/l during the examination or previous diagnosis
of hyperlipidemia, or the use of lipid-lowering medications.
Diabetes mellitus was defined as glycated hemoglobin ≥6.5%
during the examination, or previous diagnosis of diabetes
mellitus, or the use of glucose-lowering medications.
Neuroimaging
MRI scans of all the participants from both EDIS study and
the memory clinics were performed at the Clinical Imaging
Research Centre of the National University of Singapore, using
a 3T Siemens Magnetom Trio Tim Scanner system with a 32-
channel head coil. The standardized neuroimaging protocol in
this study included a three dimensional T1-weighted sequence,
a T2-weighted sequence, fluid-attenuated inversion recovery
(FLAIR), and a susceptibility weighted image (SWI). Quantitative
MRI analyses were performed using automated segmentation
procedures at the Department of Medical Informatics, Erasmus
University Medical Center, the Netherlands, using a model-
based methodology (FreeSurfer, v.5.1.0) on T1 weighted images
(TR = 7.2ms, TE = 3.3ms, matrix = 256 × 256 × 180
mm3). For each participant, the following MRI-based markers
were analyzed:
• CMBs were graded on SWI sequence according to the Brain
Observer Micro Bleed Scale (20). CMBs were manually
classified in both lobes (left and right) into two different
locations: lobar (cortex/gray-white junction, subcortical white
matter) and deep (basal ganglia, thalamus, internal and
external capsule, brainstem, and cerebellum). CMBs were
then further divided into three groups: strictly lobar CMBs
(presence of CMBs exclusively in lobar region), strictly deep
CMBs (presence of CMBs exclusively in deep region), and
mixed CMBs (CMBs distributed in both lobar and deep
locations). The total number of CMBs in each location was
recorded and calculated as the sum of strictly lobar, strictly
deep, and mixed CMBs. Total CMBs was further categorized
into three groups according to CMBs burden: 0 CMB, presence
of 1 CMB, and presence of ≥2 CMBs (21).
• Lacunes were defined as round or ovoid lesions involving the
subcortical regions, 3–15mm in diameter, with a low signal on
T1-weighted images and FLAIR, a high signal on T2-weighted
images and a hyperintense rim with a center following the
cerebrospinal fluid intensity (22). Similarly, lacunes were
classified into two different locations: lobar (when located
in frontal, parietal, temporal, occipital, insula, and centrum
semiovale) and deep (when located in basal ganglia, thalamus,
internal, and external capsule) (23). Lacunes were further
divided into three groups: strictly lobar lacunes (presence
of lacunes exclusively in lobar region), strictly deep lacunes
(presence of lacunes exclusively in deep region), and mixed
lacunes (presence of lacunes distributed in both lobar and
deep locations). The total number of lacunes in each location
was recorded and was calculated as sum of strictly lobar,
strictly deep, and mixed lacunes. Total lacunes were further
categorized into three groups according to lacunes burden: 0
lacune, presence of 1 lacune, and presence of ≥2 lacunes.
• ePVS were defined as round or linear hypointense lesions on
T1 weighted and hyperintense lesion on T2 weighted images.
When lesion is≥1mm, it is considered as dilated. In this study,
ePVS were visually counted in four different regions of the
brain: centrum semiovale, basal ganglia, mesencephalon, and
hippocampus. Centrum semiovale EPVS were graded in the
slice 10mm above the lateral ventricle, whereas basal ganglia
EPVS were graded to the level of the anterior commissure.
ePVS in mesencephalon and hippocampus, were graded in
all slices (24). Total ePVS was calculated as sum of centrum
semiovale, basal ganglia, hippocampus, and mesencephalon
ePVS. Due to the small number of ePVS inmesencephalon and
hippocampus, we did not use these regions in further analysis.
• WMH volume was quantified using T1 and T2 weighted
images. The image preprocessing steps and the tissue
classification algorithm have been described elsewhere (25).
Briefly, a k-nearest-neighbor (kNN) classifier technique was
used to classify voxels into cerebrospinal fluid (CSF), gray
matter, normal white matter and WMH. Volumes (ml)
were calculated for all biomarkers from these segmentations.
Region-specific WMH volume was calculated for frontal,
parietal, occipital, and temporal lobes. Total WMH volume
was calculated as the sum of WMH volumes in the above
mentioned five regions. In this study, frontal WMH volume
was classified as anterior and sum of parietal and occipital
WMH volume as posterior (26–28). Total WMH volume
was further categorized into tertiles to represent severity
of WMH.
Intra-rater agreement for lacunes, CMBs, and ePVS was good to
excellent, which has been published previously (8, 29).
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Statistical Analysis
CMBs and lacunes were treated as counts and categorical
variables. For categorical data, we classify CMB and lacunes as:
presence vs. absence and 1 vs. 0, ≥2 vs. 0, and by location
(strictly lobar vs. no, strictly deep vs. no, and mixed vs.
no).WMH volumes were logarithmically transformed due to
skewed distribution and were divided into tertiles (second tertile
vs. first tertile and third tertile vs. first tertile). We chose to
present the results with ePVS as count variable in this study
because the numbers of participants with no ePVS were too few
in binary category. SVD markers were treated as determinants
and ePVS as outcomes. In our secondary analysis, we divided our
study subjects into two groups i.e., NCI group which included
NCI and cognitive impairment group which included CIND
and Dementia. In order to analyze the association between
location and severity of SVDmarkers with ePVS counts, negative
binomial regression was constructed with rate ratios (RR) and
95% confidence intervals (CI). All models were adjusted for
age, gender, hypertension, hyperlipidemia, and diabetes. Results
were considered significant at p < 0.05. In view of multiple
testing performed between SVD and ePVS, we used Bonferroni
correction to obtain revised statistical significance level of 0.05/2
∼ 0.025. All the data were analyzed using SPSS software
package (version 25).
RESULTS
The characteristics of the study population from the memory
clinic and EDIS study is shown in Table 1. Patients frommemory
clinic were older. EDIS participants had burden of hypertension
where as participants from memory clinic had higher SVD
burden. The median number (interquartile range) of total ePVS
in memory clinic was 17.0 (11.0) and in EDIS, 7.0 (8.0).
The association between severity of SVD with total and
region-specific ePVS in the memory clinic population is shown
in Table 2. Increased severity of CMBs, lacunes and WMH was
not associated with increased number of ePVS. Region-specific
analysis also showed that increased severity of SVD was not
associated with centrum semiovale ePVS and basal ganglia ePVS.
Similarly, stratifying CMBs and lacunes into 0, 1, and ≥2 and
WMH volume into tertiles did not change the results.
The association between locations of SVD with ePVS in
memory clinic population is shown in Table 3. Increased number
of lobar, deep, and mixed CMBs as well as lacunes and higher
volumes of anterior and posteriorWMHwere not associated with
ePVS (total ePVS, centrum semiovale ePVS, and basal ganglia
ePVS). When treating CMBs and lacunes as categorical data
(presence vs. absence) in regression analysis, no association was
again observed (Supplementary Table 1).
The association between severity of SVD with ePVS in EDIS
participants is shown in Table 4. Increased numbers of CMBs,
lacunes, and increased severity of WMH volume were not
associated with increased number of ePVS. Furthermore, region-
specific analysis of ePVS as centrum semiovale ePVS and basal
ganglia ePVS also did not show any significant association with
SVD. However, on stratifying CMBs and lacunes into 1 vs. 0 and
TABLE 1 | Characteristics of study participants.
Baseline variables Memory clinic
(n = 375)
EDIS
(n= 583)
Demographic factors
Age, median (IQR) 73 (12) 70 (11)
Gender (Female), n (%) 199 (53.1) 319 (54.7)
Cardiovascular determinants
Hypertension, n (%) 264 (70.4) 485 (83.2)
Hyperlipidemia, n (%) 273 (72.8) 412 (70.7)
Diabetes, n (%) 132 (35.2) 176 (30.2)
MRI markers
Presence of Lacunes, n (%) 106 (28.3) 106 (18.2)
Strictly lobar lacunes, n (%) 32 (8.5) 50 (8.6)
Strictly deep lacunes, n (%) 43 (11.5) 27 (4.6)
Mixed lacunes, n (%) 31 (8.3) 29 (5.0)
Presence of CMBs, n (%) 156 (41.6) 215 (36.5)
Strictly lobar CMBs, n (%) 81 (21.6) 110 (18.9)
Strictly deep CMBs, n (%) 30 (8.0) 32 (5.5)
Mixed CMBs, n (%) 45 (12.0) 73 (12.5)
Total WMH volume, ml, median (IQR) 3.5 (11.0) 2.1 (6.0)
Anterior WMH volume, ml, median (IQR) 0.7 (3.3) 0.3 (1.4)
Posterior WMH volume, ml, median (IQR) 0.5 (3.1) 0.3 (1.5)
Total ePVS, median (IQR) 17.0 (11) 7.0 (8.0)
Centrum semiovale ePVS, median (IQR) 10.0 (9.0) 3.0 (5)
Basal ganglia ePVS, median (IQR) 3.0 (3) 2.0 (3)
SD, standard deviation; IQR, inter quartile range;WMH, white matter hyperintensity; ePVS,
enlarged perivascular spaces; EDIS, Epidemiology of Dementia in Singapore.
TABLE 2 | Association between severity of SVD and ePVS (Memory clinic).
SVD markers Total ePVS
RR (95% CI)
Centrum
semiovale ePVS
RR (95% CI)
Basal ganglia
ePVS
RR (95% CI)
Total CMBs 1.00 (0.99, 1.01) 1.00 (0.98, 1.01) 1.01 (0.99, 1.02)
1 CMB 0.96 (0.71, 1.30) 1.00 (0.74, 1.36) 0.96 (0.69, 1.33)
≥2 CMBs 1.06 (0.83, 1.36) 1.02 (0.80, 1.31) 1.04 (0.79, 1.37)
Total lacunes 1.04 (0.93, 1.16) 0.98 (0.87, 1.01) 1.10 (0.98, 1.25)
1 lacune 1.13 (0.84, 1.51) 1.13 (0.84, 1.52) 0.98 (0.71, 1.36)
≥2 lacunes 1.17 (0.76, 1.49) 0.88 (0.62, 1.24) 1.37 (0.96, 1.97)
Total WMH volume 1.00 (0.94, 1.00) 1.00 (0.99, 1.00) 1.00 (0.99, 1.00)
Second tertile 1.04 (0.80, 1.35) 1.06 (0.82, 1.39) 0.96 (0.72, 1.28)
Third tertile 1.09 (0.83, 1.43) 1.07 (0.82, 1.41) 1.02 (0.75, 1.37)
RR, rate ratio; CI, confidence interval; CMBs, cerebral microbleeds; ePVS, enlarged
perivascular spaces; WMH, white matter hyperintensity. All values adjusted for age,
gender, hypertension, hyperlipidemia, and diabetes.
≥2 vs. 0; presence of ≥2 lacunes [RR = 1.61, 95% CI = 1.3, 2.30,
p= 0.009] and presence of≥2 CMBs [RR= 1.40, 95% CI= 1.08,
1.83, p = 0.012] were associated with basal ganglia ePVS. Higher
volume ofWMH in third tertile was associated with basal ganglia
ePVS [RR = 1.41, 95% CI = 1.10, 1.81, p = 0.006]. Moreover,
presence of ≥2 lacunes was found to be associated with reduced
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TABLE 3 | Association between location of SVD and ePVS (Memory clinic).
SVD markers Total ePVS
RR (95% CI)
Centrum
semiovale ePVS
RR (95% CI)
Basal ganglia
ePVS
RR (95% CI)
Strictly lobar CMBs 1.00 (0.98, 1.02) 0.99 (0.97, 1.01) 1.01 (0.99, 1.03)
Strictly deep CMBs 1.01 (0.88, 1.15) 0.99 (0.86, 1.12) 1.02 (0.87, 1.20)
Mixed CMBs 1.00 (0.99, 1.02) 1.00 (0.98, 1.01) 1.01 (0.99, 1.02)
Strictly lobar lacunes 0.99 (0.76, 1.29) 0.93 (0.71, 1.23) 1.03 (0.78, 1.35)
Strictly deep lacunes 1.00 (0.79, 1.27) 0.98 (0.77, 1.25) 0.92 (0.71, 1.18)
Mixed lacunes 1.05 (0.92, 1.19) 1.00 (0.88, 1.14) 1.15 (1.00, 1.32)
Anterior WMH volume 1.00 (0.98, 1.01) 0.99 (0.98, 1.01) 1.00 (0.98, 1.02)
Posterior WMH volume 1.00 (0.99, 1.01) 1.00 (0.99, 1.01) 1.00 (0.99, 1.01)
RR, rate ratio; CI, confidence interval; CMBs, cerebral microbleeds; ePVS, enlarged
perivascular spaces; WMH, white matter hyperintensity. All values adjusted for age,
gender, hypertension, hyperlipidemia, and diabetes.
TABLE 4 | Association between severity of SVD and ePVS (EDIS).
SVD markers Total ePVS
RR (95% CI)
Centrum
semiovale ePVS
RR (95% CI)
Basal ganglia
ePVS
RR (95% CI)
Total CMBs* 1.00 (0.99, 1.01) 0.99 (0.98, 1.00) 1.00 (0.99, 1.01)
1 CMB 1.04 (0.84, 1.30) 0.93 (0.73, 1.18) 1.09 (0.85, 1.40)
≥2 CMBs 1.18 (0.93, 1.51) 1.00 (0.78, 1.29) 1.40 (1.08, 1.83)*
Total lacunes 1.07 (0.93, 1.22) 0.89 (0.76, 1.04) 1.21 (0.70, 1.92)
1 lacune 1.33 (1.00, 1.76) 1.43 (1.06, 1.92) 1.14 (1.00, 1.48)
≥2 lacunes 1.05 (0.75, 1.47) 0.61 (0.42, 0.88)* 1.61 (1.13, 2.30)*
Total WMH volume 1.00 (0.99, 1.12) 1.00 (0.99, 1.00) 1.00 (0.99, 1.00)
Second tertile 0.97 (0.78, 1.20) 0.90 (0.72, 1.14) 1.15 (0.90, 1.47)
Third tertile 1.07 (0.85, 1.34) 0.81 (0.63, 1.03) 1.41 (1.10, 1.81)*
RR, rate ratio; CI, confidence interval; CMBs, cerebral microbleeds; ePVS, enlarged
perivascular spaces; WMH, white matter hyperintensity; EDIS, Epidemiology of Dementia
in Singapore. All values adjusted for age, gender, hypertension, hyperlipidemia, and
diabetes. Bold values represents statistically significant associations at p < 0.05.
*Statistically significant after Bonferroni correction (0.05/2 ∼ 0.025).
centrum semiovale ePVS counts [RR= 0.61, 95% CI= 0.42, 0.88,
p= 0.009]. These associations survived multiple testing.
The association between locations of SVD with ePVS
in EDIS participants is shown in Table 5. Location-specific
analysis of SVD did not show any significant association with
total ePVS counts. On repeating this analysis with region-
specific ePVS counts, increased number of lobar, deep and
mixed CMBs, and lacunes were not associated with centrum
semiovale ePVS. However, there was borderline association
between increased number of strictly lobar lacunes [RR = 1.27,
95% CI = 1.00, 1.62, p = 0.055] and mixed lacunes
[RR = 1.16, 95% CI = 0.99, 1.36, p = 0.070] with basal
ganglia ePVS. Higher anterior and posterior WMH volumes
were not associated with centrum semiovale ePVS or with basal
ganglia ePVS.
In EDIS participants, when treating CMBs and lacunes as
categorical data (presence vs. absence), no significant association
was again observed between presence of SVD and ePVS.
TABLE 5 | Association between location of SVD and ePVS (EDIS study).
SVD markers Total ePVS RR
(95% CI)
Centrum
semiovale ePVS
RR (95% CI)
Basal ganglia
ePVS
RR (95% CI)
Total CMBs 1.00 (0.99, 1.01) 0.99 (0.98, 1.00) 1.00 (0.99, 1.01)
Strictly lobar CMBs 0.98 (0.83, 1.16) 0.92 (0.78, 1.10) 1.10 (0.92, 1.32)
Strictly deep CMBs 1.22 (0.84, 1.77) 1.27 (0.86, 1.88) 0.88 (0.57, 1.35)
Mixed CMBs 1.00 (0.99, 1.01) 0.99 (0.98, 1.00) 1.00 (0.99, 1.01)
Strictly lobar lacunes 1.12 (0.88, 1.42) 1.04 (0.80, 1.36) 1.27 (1.00, 1.62)
Strictly deep lacunes 1.23 (0.86, 1.75) 1.21 (0.83, 1.77) 1.25 (0.85, 1.83)
Mixed lacunes 1.00 (0.86, 1.16) 0.78 (0.63, 0.94) 1.16 (0.99, 1.36)
Anterior WMH volume 1.00 (0.99, 1.01) 1.00 (0.99, 1.01) 1.01 (0.99, 1.02)
Posterior WMH volume 1.00 (0.99, 1.01) 1.00 (0.99, 1.01) 1.00 (0.99, 1.01)
RR, rate ratio; CI, confidence interval; CMBs, cerebral microbleeds; ePVS, enlarged
perivascular spaces; WMH, white matter hyperintensity; EDIS, Epidemiology of Dementia
in Singapore. All values adjusted for age, gender, hypertension, hyperlipidemia, and
diabetes.
However, there was border line association between presence of
CMBs [RR = 1.23, 95% CI = 0.99, 1.51, p = 0.058] and lacunes
[RR = 1.29, 95% CI = 0.97, 1.91, p = 0.056] with basal ganglia
ePVS. Region-specific analysis of CMBs and lacunes showed
border line association between mixed CMBs [RR = 1.18, 95%
CI = 0.94, 1.09, p = 0.057], and mixed lacunes [RR = 1.36,
95% CI = 0.74, 2.27, p = 0.054] with basal ganglia ePVS
(Supplementary Table 2).
On performing secondary analysis among cognitive
impairment and NCI groups, we found location and severity
of SVD markers were not associated with ePVS counts in
memory clinic and population-based setting. However, in EDIS
study, presence of ≥2 lacunes [RR = 1.59, 95% CI = 1.09,
2.31, p = 0.015], ≥2 CMBs [RR = 1.40, 95% CI = 1.08,
1.98, p = 0.014], and higher volume of WMH in third tertile
[RR = 1.45, 95% CI = 1.08, 1.94, p = 0.012] were associated
with basal ganglia ePVS in cognitively impaired group only.
Moreover, among individuals with NCI in EDIS study, increased
number of strictly lobar lacunes [RR= 0.37, 95% CI= 0.17, 0.77,
p = 0.008] and higher WMH volume in third tertile [RR = 0.48,
95% CI = 0.29, 0.78, p = 0.003], more specifically anterior
[RR = 0.07, 95% CI = 0.66, 0.90, p = 0.001] and posterior
WMH volume [RR = 0.76, 95% CI = 0.66, 0.88, p < 0.001] were
associated with lower centrum semiovale ePVS counts [data
not shown].
DISCUSSION
This study demonstrated that increased severity of SVD markers
were not associated with total ePVS counts in memory clinic
and population-based settings. Region specific analysis did not
change these results. However, in EDIS study presence of ≥2
lacunes, ≥2 CMBs, and higher volume of WMH were associated
with basal ganglia ePVS independent of age, gender, and vascular
risk factors. We did not find an association between location of
SVD with ePVS in centrum semiovale and basal ganglia.
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Till date, this is the first study to examine the association
between location and severity of SVD with total and region
specific ePVS counts. Previous studies have shown that lobar
CMBs were associated with centrum semiovale ePVS and
deep CMBs with basal ganglia ePVS (12, 15). Furthermore,
higher WMH volume was associated with basal ganglia ePVS
(12). However, in this study we found that total and region
specific ePVS counts were not associated with location of SVD
in both memory clinic and population-based settings. This
might be due to the fact that first, ePVS are considered as
an early MRI feature in the spectrum of SVD markers (16).
Previous studies have shown that the WMH, CMBs, ePVS,
and lacunes co-occur suggesting a common pathophysiological
mechanism underlying these lesions (30). Second, during the
different stages of cognitive impairment, other factors such
as inflammation, amyloid, tau may attenuate the effect the
traditional cardiovascular risk factors such as hypertension,
hyperlipidemia, and diabetes (31, 32). Third, cerebral amyloid
angiopathy and hypertensive arteriopathy may be due to two
separate mechanisms in preclinical stages, but at the advanced
stage, they co-occur and manifest as mixed pathology (30). Since
the participants of the memory clinic have a higher burden of
cardiovascular risk factors, we speculate that they might already
be in more advanced stage of cerebrovascular damage and hence
a ceiling effect is likely to be observed (8), which may explain
the lack of association between location and severity of SVD with
ePVS. Moreover, there might be differences in study population
(hospital/memory clinic vs. population-based), different MRI
modalities i.e., field strength (1.5T vs. 3T vs. 7 T), methods
in ePVS grading (whole brain vs. particular slice vs. particular
hemisphere), sequences used and variation in risk factor profile
as well as the inclusion criteria of the study population. It has
been shown that, perivascular spaces are present in abundance
throughout the healthy brain (7) and when enlarged can be
visualized on MRI (8). It is possible that ePVS differ from other
markers of SVD andmay represent a non-pathological process of
aging with no clinical consequences.
The prevalence of SVD has been suggested to differ among
ethnicities due to differences in vascular risk factors, genetic,
and environmental susceptibility (29). It is reported that the
burden of SVD is higher in Asians compared to Caucasians
due to higher prevalence of cardiovascular risk factors (33).
Hence, we speculate that Asians with higher SVD burden would
have higher number of ePVS compared to Caucasians. By
contrast, the ePVS counts in both memory clinics and EDIS
study were lower than previous studies (7, 10, 17, 34, 35).
This difference may be attributed to different grading method
for ePVS. Similar results were also mentioned in a recent
meta-analysis which included EDIS and other community-based
samples from Austria, Hong Kong, Netherlands, and Germany.
Despite using a harmonized method to grade ePVS in each
study, Asians had lower number of ePVS, especially lowest in
Hong Kong (mean ePVS = 2.1) compared to other cohorts
in that study [Austria; mean ePVS = 30.8, Netherlands; mean
ePVS= 16.7, Germany; mean ePVS= 8.2] (8).
Previous neuropathological studies have shown co-occurrence
of ePVS with other SVD markers such as CMBs, WMH, and
lacunes. However, it is difficult to conclude the chronological
order of the occurrence of these markers as post-mortem samples
are obtained at later stage of life when there is significant SVD
burden. It is not clear that ePVS precede, follow or co-occur
together with other SVD. We cannot exclude the possibility
that ePVS of ≥1mm may be non-pathogenic and may not have
any significant effect on SVD. It has been shown that large
perivascular spaces (≥3mm in diameter) were associated with
MRI markers of SVD and increased risk of dementia (36). We
postulate that smaller ePVS are non-pathological and hence are
not associated with SVD in this study.
Interestingly, in EDIS study, we found that the presence of≥2
lacunes, CMBs, and higher WMH volume were associated with
basal ganglia ePVS.We only found this association in population-
based setting but not in memory-clinic study. Although no
direct conclusion can be drawn from this study with respect
to the association between ePVS and SVD, these results should
be interpreted with caution. Notably, EDIS participants were
relatively younger and had lower burden of vascular risk factors
especially lower diabetes and hyperlipidemia hence, they may
be at early stage of disease, whereas memory clinic participants
were older and had higher burden of vascular risk factors and
are at later stage of cognitive impairment. Furthermore, EDIS
participants had a higher burden of hypertension compared
to memory clinic subjects, which might have influenced the
association however, previous studies on association between
vascular risk factors and ePVS are controversial. It has been
shown ePVS were associated with vascular risk factors such as
hypertension (13–16) but a recent study did not report such
findings (7). Hence, this finding leads us to further confirm
that ePVS may be early marker of SVD. However, these results
should be interpreted with caution. Interestingly in EDIS study,
we found that the presence of ≥2 lacunes was associated with
lower ePVS counts in centrum semiovale. In subgroup analysis,
among the individuals with NCI in EDIS study increased number
of strictly lobar lacunes was associated with lower ePVS count in
centrum semiovale. The possible reason might be, due to similar
MRI characteristics of ePVS and lacunes, where several ePVS
may have been mis-graded as lacunes or vice versa and thus we
might have underestimated the exact numbers of ePVS (22, 37–
39). Similarly, in subjects with NCI in EDIS study, higher WMH
volume were associated with lower counts of centrum semiovale
ePVS. This might be explained by the fact that extensive WMH
obscures ePVS grading especially in centrum semiovale and
hence under estimates PVS counting in that region.
Our study has some limitations. First, as this is a cross-
sectional study, we were unable to determine the cause-effect
relationship and also the chronological order of SVD and
temporal change of SVD over time. Second, even though we
adjusted for several risk factors such as age, gender, hypertension,
diabetes, and hyperlipidemia, we cannot ignore the possibility
of residual confounding. Third, ePVS were graded at one
particular slice for basal ganglia and centrum semiovale, we may
have missed other possible ePVS. However, this method has
shown strong correlation with whole brain grading approach
(9). Fourth, as this study was conducted in Asian population,
our results are not generalizable to other ethnicities. Fifth,
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the data on ≥3mm ePVS is only present in EDIS study.
There were only 25 subjects with ePVS ≥3mm in this study.
With this small number of cases, we were unable to find
any association. Hence we are unable to perform analysis
comparing the association of ePVS and SVD in small ePVS
(≥1mm) and large ePVS (≥3mm). Strength of this study
include, use of 2 different population i.e., memory clinic
and population-based with different risk factor profile and
SVD burden. All MRIs were done on 3T scanner and SVD
markers were graded blinded to clinical history following
similar protocol.
Our findings demonstrated that ePVS counts were not
associated with markers of SVD in memory clinic and
population-based settings in Asia. However, in population-based
setting presence of ≥2 lacunes, ≥2 CMBs, and higher WMH
volume were associated with basal ganglia ePVS. Our results need
to be studied further in large cohorts with cross-sectional and
longitudinal designs using consistent and harmonized methods
for ePVS so as to understand the underlying mechanism of
different SVD markers in subclinical and clinical phases as well
as for predicting cognitive decline.
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